Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.

Andrews CP, Martin BG, Jacobs RL, Mohar DE, Diaz JD, Amar NJ, Kaiser HB, Vandewalker ML, Bernstein J, Toler WT, Prillaman BA, Dalal AA, Lee LA, Philpot EE.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):128-38. doi: 10.2500/aap.2009.30.3204.

PMID:
19463203
2.

Loratadine provides early symptom control in seasonal allergic rhinitis.

Kaiser HB, Gopalan G, Chung W.

Allergy Asthma Proc. 2008 Nov-Dec;29(6):654-8. doi: 10.2500/aap.2008.29.3166.

PMID:
18831859
3.

Compliance and noncompliance in asthma.

Kaiser HB.

Allergy Asthma Proc. 2007 Sep-Oct;28(5):514-6.

PMID:
18034967
4.

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.

Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE.

J Allergy Clin Immunol. 2007 Jun;119(6):1430-7. Erratum in: J Allergy Clin Immunol. 2010 May;125(5):1068.

PMID:
17418384
5.

Relationship of complete respiratory dysfunction: one linked airway. A selective clinical discussion.

Kaiser HB.

Allergy Asthma Proc. 2005 May-Jun;26(3):170-2. Review.

PMID:
16119029
6.

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.

Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.

Ann Allergy Asthma Immunol. 2005 Apr;94(4):465-72.

PMID:
15875528
7.

Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity.

Kaiser HB, Liao Y, Diener P, Leahy MJ, Garcia J, Georges G.

Allergy Asthma Proc. 2004 Nov-Dec;25(6):423-8.

PMID:
15709453
8.

Risk factors in allergy/asthma.

Kaiser HB.

Allergy Asthma Proc. 2004 Jan-Feb;25(1):7-10. Review.

PMID:
15055554
9.

Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).

Dykewicz MS, Kaiser HB, Nathan RA, Goode-Sellers S, Cook CK, Witham LA, Philpot EE, Rickard K.

Ann Allergy Asthma Immunol. 2003 Jul;91(1):44-8.

PMID:
12877448
10.

Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma.

Harrison LI, Kurup S, Wagner C, Ekholm BP, Larson JS, Kaiser HB.

Eur J Clin Pharmacol. 2002 Jun;58(3):197-201.

PMID:
12107606
11.

Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.

Kaiser HB, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, Mendelson LM, Rooklin AR, Sholler LJ, Stricker WW, Harrison JE, Danzig MR, Lorber RR.

Am J Ther. 1998 Jul;5(4):245-51.

PMID:
10099066
12.

Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies.

Bronsky EA, Falliers CJ, Kaiser HB, Ahlbrandt R, Mason JM.

Allergy Asthma Proc. 1998 May-Jun;19(3):135-41.

PMID:
9642436
13.

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Wood CC.

Allergy Asthma Proc. 1998 Jan-Feb;19(1):23-9.

PMID:
9532321
14.

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.

Bronsky EA, Aaronson DW, Berkowitz RB, Chervinsky P, Graft D, Kaiser HB, Moss B, Nathan RA, Pearlman DS, Ratner PH, Adelglass JM, Southern DL, van Bavel J, Hampel F, Stricker WE, Fourré JA, Cuss FM, Nolop KB.

Ann Allergy Asthma Immunol. 1997 Jul;79(1):51-6.

PMID:
9236500
15.

A novel breath actuated device (Autohaler) consistently actuates during the early phase of inspiration.

Marshik PL, Larsen JS, Leach CL, Halverson PC, Ekholm BP, Amies MH, Kaiser HB, Weisberg SC, Sellers JA.

J Aerosol Med. 1995 Summer;8(2):187-95.

PMID:
10155353
16.

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Roszko P, Zegarelli E, Wood CC.

J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1128-32.

PMID:
7751529
17.

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.

Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM.

Ann Intern Med. 1993 Dec 1;119(11):1059-66.

PMID:
8239223
18.

Administration errors with a conventional metered dose inhaler versus a novel breath actuated device.

Larsen JS, Hahn M, Kochevar JW, Morris RJ, Kaiser HB, Weisberg SC, Halverson PC, Quessy SN.

Ann Allergy. 1993 Aug;71(2):103-6.

PMID:
8346860
19.

Cetirizine in allergic rhinitis.

Kaiser HB.

Pediatr Allergy Immunol. 1993;4(4 Suppl):44-6. Review. No abstract available.

PMID:
8353659
20.

Sensitivity of FEV1 response following one and two inhalations of albuterol: a pilot study.

Quessy SN, Morris RJ, Larsen JS, Kaiser HB, Weisberg SC, Halverson PC.

J Asthma. 1991;28(5):323-8.

PMID:
1938767
Items per page

Supplemental Content

Loading ...
Support Center